Shopping Cart 0
Cart Subtotal
USD 0

Anti-Viral Drug Therapy Global Market Report 2020-30: Covid 19 Implications and Growth

Bundle Purchase

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
USD 4000

Access to Printed Report; No Soft Copy
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : Printed Publication/ Book by Post

Hard Copy License
USD 4000

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
USD 6000

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

CD-Rom
USD 4000

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
USD 8000

Details

Major players in the anti-viral drug therapy market are AbbVie Inc., Bristol-Myers-Squibb, Cipla, F. Hoffmann-La Roche Ltd, Gilead Sciences Inc, GlaxoSmithKline, Johnson & Johnson, Merck & Co., Inc., Dr. Reddy's Laboratories Ltd, and AstraZeneca plc.
 
The global anti-viral drug therapy market is expected to grow from USD 52.2 billion in 2019 to about USD 59.9 billion in 2020 as there is a surge in demand for antiretroviral drugs used in the treatment of Covid-19 patients. The market is expected to stabilize and reach USD 62.6 billion at a CAGR of 4.6% through 2023.
 
The anti-viral drug therapy market consists of sales of anti-viral drugs used for the treatment of viral infections, such as human immunodeficiency virus (HIV), hepatitis, influenza and novel coronavirus. Antiviral drugs do not kill their target pathogen, instead they inhibit the development of those viruses. The anti-viral drugs establishments are primarily engaged in the manufacturing of DNA polymerase inhibitors, reverse transcriptase inhibitors, protease inhibitors, neuraminidase inhibitors, and others.
 
The demand for anti-viral drugs is anticipated to grow at a rapid pace due to the novel coronavirus outbreak. As there are no vaccines and potential treatments for Covid-19, companies are trying to repurpose existing drugs in the fight against the novel coronavirus. The use of certain existing anti-viral drugs for the covid-19 treatment is contributing to the growth of anti-viral drugs market. However, if any of these drugs under trails show further promising results in treating the coronavirus infection, the anti-viral market will see further growth.
 
North America was the largest region in the anti-viral drug therapy market in 2019. The anti-viral drug therapy market in Asia-Pacific is forecasted to register the highest CAGR during 2019-2023.
 
The anti-viral drug therapy market covered in this report is segmented by drug class into DNA polymerase inhibitors, reverse transcriptase inhibitors, protease inhibitors, neuraminidase inhibitors, others and by application into HIV, hepatitis, herpes, influenza, others.
 
In February 2020, GeoVax, a US-based pharmaceutical company, and BravoVax, a China-based pharmaceutical company, have announced plans to develop a coronavirus cure in the form of vaccine based on the former's MVA-VLP vaccine platform. BravoVax will be responsible for testing and manufacturing the vaccine as well as coordinating with the public health and regulatory authorities in China. GeoVax's Modified Vaccinia Ankara platform enables enhanced expression and stable transgenes during the manufacturing process. Combined with immunogenicity of Virus Like Particles (VLPs), the technology enables the production of vaccines. The collaboration between these two companies is to develop a coronavirus vaccine.
 
Increasing public-private funding for life science research globally is expected to drive the growth of anti-viral drug therapy market . Currently, there are no drugs or vaccines approved for treatment of Covid-19 disease, however, there are several vaccines and drugs in pipeline, and are yet to be approved or launched. Governments around the world announced new grant funds for researchers in vaccines, treatment and diagnostics. Canada government announced CUSD 275M for coronavirus research. Wellcome and the Gates Foundation announced they are joining forces with the credit card company MasterCard in a USD 125 million push to speed up development of drugs for treating COVID-19 infections. Hence increasing public-private funding for life science research will enhance the research and development which drive the growth of covid-19 anti-viral drug therapy market.
 
Companies in the anti-viral drug therapy market are continuously innovating through technological advancements to develop drugs to treat different viral infections. Biopharmaceutical companies are developing vaccines for the treatment of novel coronavirus. Technological advances in the pharmaceutical sector include development of nucleic acid vaccines that are DNA- and RNA-based, and which enable the human body to produce vaccine antigen. Applied DNA Sciences' subsidiary LineaRx and Takis Biotech formed a joint venture to develop a linear DNA vaccine as a treatment for coronavirus. The JV will use Polymerase Chain Reaction (PCR)-based DNA manufacturing technology to develop the vaccine. Such initiatives and activities are projected to support market growth to a significant extent.
 
The emergence of alternative therapies such as naturopathy and homeopathy for the treatment of viral infections is negatively affecting the market. The development of covid-19 anti-viral drugs involves high R&D costs. The development of covid-19 anti-viral drugs involves high operating costs and requires a greater capital investment. Due to high R&D costs involved in drug development, there is growth in the demand for alternative medicines such as naturopathy and homeopathy. Saikosaponins (A, B2, C, and D), which are naturally occurring triterpene glycosides isolated from medicinal plants such as Bupleurum spp., Heteromorpha spp., and Scrophularia scorodonia, exert antiviral activity against HCoV-22E9. Saikosaponins inhibits viral attachment and penetration stages. The marketed drugs would be priced much higher than the actual manufacturing costs. Hence using this naturopathy and homeopathy medicines can restrain the market growth.
 
 
READ MORE

Table Of Content

Scope

1. Executive Summary

2. Anti-Viral Drug Therapy Market Market Characteristics

3. Anti-Viral Drug Therapy Market Market Size And Growth

3.1. Global Anti-Viral Drug Therapy Market Historic Market, 2015-2019, USD Billion

3.1.1. Drivers Of The Market

3.1.2. Restraints On The Market

3.2. Global Anti-Viral Drug Therapy Market Forecast Market, 2019-2023F, 2025F, 2030F, USD Billion

3.2.1. Drivers Of The Market

3.2.2. Restraints On the Market

4. Anti-Viral Drug Therapy Market Market Segmentation

4.1. Global Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

DNA Polymerase Inhibitors

Reverse Transcriptase Inhibitors

Protease Inhibitors

Neuraminidase Inhibitors

Others

4.2. Global Anti-Viral Drug Therapy Market Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

HIV

Hepatitis

Herpes

Influenza

Others

5. Anti-Viral Drug Therapy Market Market Regional And Country Analysis

5.1. Global Anti-Viral Drug Therapy Market Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

5.2. Global Anti-Viral Drug Therapy Market Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

6. Asia-Pacific Anti-Viral Drug Therapy Market Market

6.1. Asia-Pacific Anti-Viral Drug Therapy Market Market Overview

6.2. Asia-Pacific Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

7. China Anti-Viral Drug Therapy Market Market

7.1. China Anti-Viral Drug Therapy Market Market Overview

7.2. China Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,USD Billion

8. India Anti-Viral Drug Therapy Market Market

8.1. India Anti-Viral Drug Therapy Market Market Overview

8.2. India Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

9. Japan Anti-Viral Drug Therapy Market Market

9.1. Japan Anti-Viral Drug Therapy Market Market Overview

9.2. Japan Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

10. Australia Anti-Viral Drug Therapy Market Market

10.1. Australia Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

11. Indonesia Anti-Viral Drug Therapy Market Market

11.1. Indonesia Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

12. South Korea Anti-Viral Drug Therapy Market Market

12.1. South Korea Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

13. Western Europe Anti-Viral Drug Therapy Market Market

13.1. Western Europe Anti-Viral Drug Therapy Market Market Overview

13.2. Western Europe Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

14. UK Anti-Viral Drug Therapy Market Market

14.1. UK Anti-Viral Drug Therapy Market Market Overview

14.2. UK Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

15. Germany Anti-Viral Drug Therapy Market Market

15.1. Germany Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

16. France Anti-Viral Drug Therapy Market Market

16.1. France Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

17. Eastern Europe Anti-Viral Drug Therapy Market Market

17.1. Eastern Europe Anti-Viral Drug Therapy Market Market Overview

17.2. Eastern Europe Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

18. Russia Anti-Viral Drug Therapy Market Market

18.1. Russia Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

19. North America Anti-Viral Drug Therapy Market Market

19.1. North America Anti-Viral Drug Therapy Market Market Overview

19.2. North America Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

20. USA Anti-Viral Drug Therapy Market Market

20.1. USA Anti-Viral Drug Therapy Market Market Overview

20.2. USA Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

21. South America Anti-Viral Drug Therapy Market Market

21.1. South America Anti-Viral Drug Therapy Market Market Overview

21.2. South America Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

22. Brazil Anti-Viral Drug Therapy Market Market

22.1. Brazil Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

23. Middle East Anti-Viral Drug Therapy Market Market

23.1. Middle East Anti-Viral Drug Therapy Market Market Overview

23.2. Middle East Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

24. Africa Anti-Viral Drug Therapy Market Market

24.1. Africa Anti-Viral Drug Therapy Market Market Overview

24.2. Africa Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

25. Anti-Viral Drug Therapy Market Market Competitive Landscape And Company Profiles

25.1. Anti-Viral Drug Therapy Market Market Competitive Landscape

25.2. Anti-Viral Drug Therapy Market Market Company Profiles

25.2.1. AbbVie Inc.

25.2.1.1. Overview

25.2.1.2. Products and Services

25.2.1.3. Strategy

25.2.1.4. Financial Performance

25.2.2. Bristol-Myers-Squibb

25.2.2.1. Overview

25.2.2.2. Products and Services

25.2.2.3. Strategy

25.2.2.4. Financial Performance

25.2.3. Cipla

25.2.3.1. Overview

25.2.3.2. Products and Services

25.2.3.3. Strategy

25.2.3.4. Financial Performance

25.2.4. F. Hoffmann-La Roche Ltd

25.2.4.1. Overview

25.2.4.2. Products and Services

25.2.4.3. Strategy

25.2.4.4. Financial Performance

25.2.5. Gilead Sciences Inc

25.2.5.1. Overview

25.2.5.2. Products and Services

25.2.5.3. Strategy

25.2.5.4. Financial Performance

26. Key Mergers And Acquisitions In The Anti-Viral Drug Therapy Market Market

27. Anti-Viral Drug Therapy Market Market Trends And Strategies

28. Anti-Viral Drug Therapy Market Market Future Outlook and Potential Analysis

29. Appendix

29.1. Abbreviations

29.2. Currencies

29.3. Research Inquiries

29.4. The Business Research Company

29.5. Copyright And Disclaimer

 


List Of Figure

Figure 1: Global Historic Market Growth, 2015-2019, USD Billion

Figure 2: Global Forecast Market Growth, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 3: Global Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 4: Global Anti-Viral Drug Therapy Market Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 5: Global Anti-Viral Drug Therapy Market Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 6: Global Anti-Viral Drug Therapy Market Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 7: Asia-Pacific, Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 8: China, Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 9: India, Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 10: Japan, Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 11: Australia, Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 12: Indonesia, Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 13: South Korea, Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 14: Western Europe, Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 15: UK, Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 16: Germany, Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 17: France, Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 18: Eastern Europe, Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 19: Russia, Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 20: North America, Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 21: USA, Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 22: South America, Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 23: Brazil, Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 24: Middle East, Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 25: Africa, Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 26: AbbVie Inc. Financial Performance

Figure 27: Bristol-Myers-Squibb Financial Performance

Figure 28: Cipla Financial Performance

Figure 29: F. Hoffmann-La Roche Ltd Financial Performance

Figure 30: Gilead Sciences Inc Financial Performance


List Of Table

Table 1: Global Historic Market Growth, 2015-2019, USD Billion

Table 2: Global Forecast Market Growth, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 3: Global Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 4: Global Anti-Viral Drug Therapy Market Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 5: Global Anti-Viral Drug Therapy Market Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 6: Global Anti-Viral Drug Therapy Market Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 7: Asia-Pacific, Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 8: China, Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 9: India, Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 10: Japan, Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 11: Australia, Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 12: Indonesia, Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 13: South Korea, Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 14: Western Europe, Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 15: UK, Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 16: Germany, Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 17: France, Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 18: Eastern Europe, Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 19: Russia, Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 20: North America, Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 21: USA, Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 22: South America, Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 23: Brazil, Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 24: Middle East, Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 25: Africa, Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 26: AbbVie Inc. Financial Performance

Table 27: Bristol-Myers-Squibb Financial Performance

Table 28: Cipla Financial Performance

Table 29: F. Hoffmann-La Roche Ltd Financial Performance

Table 30: Gilead Sciences Inc Financial Performance

Licence Rights

  • Single User License (for access by one person)
  • Site License (for access of one office location of a company)
  • Corporate License (allow access by all staff of the company)

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

1) By Drug Class: DNA Polymerase Inhibitors; Reverse Transcriptase Inhibitors; Protease Inhibitors; Neuraminidase Inhibitors; Others; 2) By Application: HIV; Hepatitis; Herpes; Influenza; Others


Companies

AbbVie Inc.; Bristol-Myers-Squibb; Cipla; F. Hoffmann-La Roche Ltd; Gilead Sciences Inc; GlaxoSmithKline; Johnson & Johnson; Merck & Co., Inc.; Dr. Reddy's Laboratories Ltd; AstraZeneca plc.,; Aurobindo Pharma; Abbott Laboratories; Schering-Plough Corporation; Pfizer Inc.; Sanofi; Regeneron Pharmaceuticals, Inc.,; Inovio Pharmaceuticals, Inc.; Novavax, Inc.; BioCryst Pharmaceuticals, Inc.

Company Profile

Company Profile Title

Major players in the anti-viral drug therapy market are AbbVie Inc., Bristol-Myers-Squibb, Cipla, F. Hoffmann-La Roche Ltd, Gilead Sciences Inc, GlaxoSmithKline, Johnson & Johnson, Merck & Co., Inc., Dr. Reddy's Laboratories Ltd, and AstraZeneca plc.
 
The global anti-viral drug therapy market is expected to grow from USD 52.2 billion in 2019 to about USD 59.9 billion in 2020 as there is a surge in demand for antiretroviral drugs used in the treatment of Covid-19 patients. The market is expected to stabilize and reach USD 62.6 billion at a CAGR of 4.6% through 2023.
 
The anti-viral drug therapy market consists of sales of anti-viral drugs used for the treatment of viral infections, such as human immunodeficiency virus (HIV), hepatitis, influenza and novel coronavirus. Antiviral drugs do not kill their target pathogen, instead they inhibit the development of those viruses. The anti-viral drugs establishments are primarily engaged in the manufacturing of DNA polymerase inhibitors, reverse transcriptase inhibitors, protease inhibitors, neuraminidase inhibitors, and others.
 
The demand for anti-viral drugs is anticipated to grow at a rapid pace due to the novel coronavirus outbreak. As there are no vaccines and potential treatments for Covid-19, companies are trying to repurpose existing drugs in the fight against the novel coronavirus. The use of certain existing anti-viral drugs for the covid-19 treatment is contributing to the growth of anti-viral drugs market. However, if any of these drugs under trails show further promising results in treating the coronavirus infection, the anti-viral market will see further growth.
 
North America was the largest region in the anti-viral drug therapy market in 2019. The anti-viral drug therapy market in Asia-Pacific is forecasted to register the highest CAGR during 2019-2023.
 
The anti-viral drug therapy market covered in this report is segmented by drug class into DNA polymerase inhibitors, reverse transcriptase inhibitors, protease inhibitors, neuraminidase inhibitors, others and by application into HIV, hepatitis, herpes, influenza, others.
 
In February 2020, GeoVax, a US-based pharmaceutical company, and BravoVax, a China-based pharmaceutical company, have announced plans to develop a coronavirus cure in the form of vaccine based on the former's MVA-VLP vaccine platform. BravoVax will be responsible for testing and manufacturing the vaccine as well as coordinating with the public health and regulatory authorities in China. GeoVax's Modified Vaccinia Ankara platform enables enhanced expression and stable transgenes during the manufacturing process. Combined with immunogenicity of Virus Like Particles (VLPs), the technology enables the production of vaccines. The collaboration between these two companies is to develop a coronavirus vaccine.
 
Increasing public-private funding for life science research globally is expected to drive the growth of anti-viral drug therapy market . Currently, there are no drugs or vaccines approved for treatment of Covid-19 disease, however, there are several vaccines and drugs in pipeline, and are yet to be approved or launched. Governments around the world announced new grant funds for researchers in vaccines, treatment and diagnostics. Canada government announced CUSD 275M for coronavirus research. Wellcome and the Gates Foundation announced they are joining forces with the credit card company MasterCard in a USD 125 million push to speed up development of drugs for treating COVID-19 infections. Hence increasing public-private funding for life science research will enhance the research and development which drive the growth of covid-19 anti-viral drug therapy market.
 
Companies in the anti-viral drug therapy market are continuously innovating through technological advancements to develop drugs to treat different viral infections. Biopharmaceutical companies are developing vaccines for the treatment of novel coronavirus. Technological advances in the pharmaceutical sector include development of nucleic acid vaccines that are DNA- and RNA-based, and which enable the human body to produce vaccine antigen. Applied DNA Sciences' subsidiary LineaRx and Takis Biotech formed a joint venture to develop a linear DNA vaccine as a treatment for coronavirus. The JV will use Polymerase Chain Reaction (PCR)-based DNA manufacturing technology to develop the vaccine. Such initiatives and activities are projected to support market growth to a significant extent.
 
The emergence of alternative therapies such as naturopathy and homeopathy for the treatment of viral infections is negatively affecting the market. The development of covid-19 anti-viral drugs involves high R&D costs. The development of covid-19 anti-viral drugs involves high operating costs and requires a greater capital investment. Due to high R&D costs involved in drug development, there is growth in the demand for alternative medicines such as naturopathy and homeopathy. Saikosaponins (A, B2, C, and D), which are naturally occurring triterpene glycosides isolated from medicinal plants such as Bupleurum spp., Heteromorpha spp., and Scrophularia scorodonia, exert antiviral activity against HCoV-22E9. Saikosaponins inhibits viral attachment and penetration stages. The marketed drugs would be priced much higher than the actual manufacturing costs. Hence using this naturopathy and homeopathy medicines can restrain the market growth.
 
 
READ MORE

Scope

1. Executive Summary

2. Anti-Viral Drug Therapy Market Market Characteristics

3. Anti-Viral Drug Therapy Market Market Size And Growth

3.1. Global Anti-Viral Drug Therapy Market Historic Market, 2015-2019, USD Billion

3.1.1. Drivers Of The Market

3.1.2. Restraints On The Market

3.2. Global Anti-Viral Drug Therapy Market Forecast Market, 2019-2023F, 2025F, 2030F, USD Billion

3.2.1. Drivers Of The Market

3.2.2. Restraints On the Market

4. Anti-Viral Drug Therapy Market Market Segmentation

4.1. Global Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

DNA Polymerase Inhibitors

Reverse Transcriptase Inhibitors

Protease Inhibitors

Neuraminidase Inhibitors

Others

4.2. Global Anti-Viral Drug Therapy Market Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

HIV

Hepatitis

Herpes

Influenza

Others

5. Anti-Viral Drug Therapy Market Market Regional And Country Analysis

5.1. Global Anti-Viral Drug Therapy Market Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

5.2. Global Anti-Viral Drug Therapy Market Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

6. Asia-Pacific Anti-Viral Drug Therapy Market Market

6.1. Asia-Pacific Anti-Viral Drug Therapy Market Market Overview

6.2. Asia-Pacific Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

7. China Anti-Viral Drug Therapy Market Market

7.1. China Anti-Viral Drug Therapy Market Market Overview

7.2. China Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,USD Billion

8. India Anti-Viral Drug Therapy Market Market

8.1. India Anti-Viral Drug Therapy Market Market Overview

8.2. India Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

9. Japan Anti-Viral Drug Therapy Market Market

9.1. Japan Anti-Viral Drug Therapy Market Market Overview

9.2. Japan Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

10. Australia Anti-Viral Drug Therapy Market Market

10.1. Australia Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

11. Indonesia Anti-Viral Drug Therapy Market Market

11.1. Indonesia Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

12. South Korea Anti-Viral Drug Therapy Market Market

12.1. South Korea Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

13. Western Europe Anti-Viral Drug Therapy Market Market

13.1. Western Europe Anti-Viral Drug Therapy Market Market Overview

13.2. Western Europe Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

14. UK Anti-Viral Drug Therapy Market Market

14.1. UK Anti-Viral Drug Therapy Market Market Overview

14.2. UK Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

15. Germany Anti-Viral Drug Therapy Market Market

15.1. Germany Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

16. France Anti-Viral Drug Therapy Market Market

16.1. France Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

17. Eastern Europe Anti-Viral Drug Therapy Market Market

17.1. Eastern Europe Anti-Viral Drug Therapy Market Market Overview

17.2. Eastern Europe Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

18. Russia Anti-Viral Drug Therapy Market Market

18.1. Russia Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

19. North America Anti-Viral Drug Therapy Market Market

19.1. North America Anti-Viral Drug Therapy Market Market Overview

19.2. North America Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

20. USA Anti-Viral Drug Therapy Market Market

20.1. USA Anti-Viral Drug Therapy Market Market Overview

20.2. USA Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

21. South America Anti-Viral Drug Therapy Market Market

21.1. South America Anti-Viral Drug Therapy Market Market Overview

21.2. South America Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

22. Brazil Anti-Viral Drug Therapy Market Market

22.1. Brazil Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

23. Middle East Anti-Viral Drug Therapy Market Market

23.1. Middle East Anti-Viral Drug Therapy Market Market Overview

23.2. Middle East Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

24. Africa Anti-Viral Drug Therapy Market Market

24.1. Africa Anti-Viral Drug Therapy Market Market Overview

24.2. Africa Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

25. Anti-Viral Drug Therapy Market Market Competitive Landscape And Company Profiles

25.1. Anti-Viral Drug Therapy Market Market Competitive Landscape

25.2. Anti-Viral Drug Therapy Market Market Company Profiles

25.2.1. AbbVie Inc.

25.2.1.1. Overview

25.2.1.2. Products and Services

25.2.1.3. Strategy

25.2.1.4. Financial Performance

25.2.2. Bristol-Myers-Squibb

25.2.2.1. Overview

25.2.2.2. Products and Services

25.2.2.3. Strategy

25.2.2.4. Financial Performance

25.2.3. Cipla

25.2.3.1. Overview

25.2.3.2. Products and Services

25.2.3.3. Strategy

25.2.3.4. Financial Performance

25.2.4. F. Hoffmann-La Roche Ltd

25.2.4.1. Overview

25.2.4.2. Products and Services

25.2.4.3. Strategy

25.2.4.4. Financial Performance

25.2.5. Gilead Sciences Inc

25.2.5.1. Overview

25.2.5.2. Products and Services

25.2.5.3. Strategy

25.2.5.4. Financial Performance

26. Key Mergers And Acquisitions In The Anti-Viral Drug Therapy Market Market

27. Anti-Viral Drug Therapy Market Market Trends And Strategies

28. Anti-Viral Drug Therapy Market Market Future Outlook and Potential Analysis

29. Appendix

29.1. Abbreviations

29.2. Currencies

29.3. Research Inquiries

29.4. The Business Research Company

29.5. Copyright And Disclaimer

 


List Of Figure

Figure 1: Global Historic Market Growth, 2015-2019, USD Billion

Figure 2: Global Forecast Market Growth, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 3: Global Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 4: Global Anti-Viral Drug Therapy Market Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 5: Global Anti-Viral Drug Therapy Market Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 6: Global Anti-Viral Drug Therapy Market Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 7: Asia-Pacific, Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 8: China, Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 9: India, Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 10: Japan, Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 11: Australia, Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 12: Indonesia, Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 13: South Korea, Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 14: Western Europe, Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 15: UK, Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 16: Germany, Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 17: France, Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 18: Eastern Europe, Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 19: Russia, Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 20: North America, Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 21: USA, Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 22: South America, Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 23: Brazil, Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 24: Middle East, Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 25: Africa, Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 26: AbbVie Inc. Financial Performance

Figure 27: Bristol-Myers-Squibb Financial Performance

Figure 28: Cipla Financial Performance

Figure 29: F. Hoffmann-La Roche Ltd Financial Performance

Figure 30: Gilead Sciences Inc Financial Performance


List Of Table

Table 1: Global Historic Market Growth, 2015-2019, USD Billion

Table 2: Global Forecast Market Growth, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 3: Global Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 4: Global Anti-Viral Drug Therapy Market Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 5: Global Anti-Viral Drug Therapy Market Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 6: Global Anti-Viral Drug Therapy Market Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 7: Asia-Pacific, Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 8: China, Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 9: India, Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 10: Japan, Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 11: Australia, Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 12: Indonesia, Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 13: South Korea, Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 14: Western Europe, Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 15: UK, Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 16: Germany, Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 17: France, Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 18: Eastern Europe, Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 19: Russia, Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 20: North America, Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 21: USA, Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 22: South America, Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 23: Brazil, Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 24: Middle East, Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 25: Africa, Anti-Viral Drug Therapy Market Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 26: AbbVie Inc. Financial Performance

Table 27: Bristol-Myers-Squibb Financial Performance

Table 28: Cipla Financial Performance

Table 29: F. Hoffmann-La Roche Ltd Financial Performance

Table 30: Gilead Sciences Inc Financial Performance

  • Single User License (for access by one person)
  • Site License (for access of one office location of a company)
  • Corporate License (allow access by all staff of the company)
To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

1) By Drug Class: DNA Polymerase Inhibitors; Reverse Transcriptase Inhibitors; Protease Inhibitors; Neuraminidase Inhibitors; Others; 2) By Application: HIV; Hepatitis; Herpes; Influenza; Others


Companies

AbbVie Inc.; Bristol-Myers-Squibb; Cipla; F. Hoffmann-La Roche Ltd; Gilead Sciences Inc; GlaxoSmithKline; Johnson & Johnson; Merck & Co., Inc.; Dr. Reddy's Laboratories Ltd; AstraZeneca plc.,; Aurobindo Pharma; Abbott Laboratories; Schering-Plough Corporation; Pfizer Inc.; Sanofi; Regeneron Pharmaceuticals, Inc.,; Inovio Pharmaceuticals, Inc.; Novavax, Inc.; BioCryst Pharmaceuticals, Inc.